Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 17 studies | 29% ± 12% | |
glutamatergic neuron | 10 studies | 41% ± 25% | |
astrocyte | 10 studies | 29% ± 13% | |
oligodendrocyte precursor cell | 9 studies | 31% ± 15% | |
fibroblast | 8 studies | 23% ± 10% | |
GABAergic neuron | 8 studies | 39% ± 21% | |
oligodendrocyte | 8 studies | 30% ± 10% | |
neuron | 7 studies | 35% ± 16% | |
macrophage | 7 studies | 28% ± 8% | |
microglial cell | 7 studies | 27% ± 8% | |
interneuron | 6 studies | 41% ± 21% | |
adipocyte | 6 studies | 25% ± 6% | |
endothelial cell of lymphatic vessel | 5 studies | 28% ± 10% | |
granule cell | 4 studies | 21% ± 4% | |
myeloid cell | 4 studies | 18% ± 2% | |
epithelial cell | 4 studies | 35% ± 12% | |
connective tissue cell | 4 studies | 17% ± 1% | |
pericyte | 4 studies | 25% ± 8% | |
smooth muscle cell | 4 studies | 21% ± 0% | |
hematopoietic precursor cell | 3 studies | 20% ± 3% | |
GABAergic interneuron | 3 studies | 26% ± 5% | |
retinal ganglion cell | 3 studies | 24% ± 2% | |
amacrine cell | 3 studies | 24% ± 7% | |
retina horizontal cell | 3 studies | 24% ± 7% | |
ciliated cell | 3 studies | 21% ± 2% | |
goblet cell | 3 studies | 27% ± 14% | |
mast cell | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2128.82 | 1445 / 1445 | 100% | 33.99 | 183 / 183 |
ovary | 100% | 3326.49 | 180 / 180 | 100% | 29.85 | 430 / 430 |
prostate | 100% | 2651.33 | 245 / 245 | 100% | 30.31 | 502 / 502 |
brain | 100% | 3184.99 | 2640 / 2642 | 100% | 38.19 | 705 / 705 |
breast | 100% | 3096.42 | 459 / 459 | 100% | 35.28 | 1117 / 1118 |
lung | 100% | 2586.27 | 577 / 578 | 100% | 30.25 | 1155 / 1155 |
thymus | 100% | 3272.28 | 653 / 653 | 100% | 34.64 | 603 / 605 |
adrenal gland | 100% | 2543.03 | 258 / 258 | 100% | 26.29 | 229 / 230 |
intestine | 100% | 2505.54 | 966 / 966 | 99% | 22.59 | 524 / 527 |
kidney | 100% | 2146.89 | 89 / 89 | 99% | 31.90 | 895 / 901 |
stomach | 100% | 1705.37 | 359 / 359 | 99% | 24.61 | 284 / 286 |
pancreas | 100% | 1377.93 | 327 / 328 | 99% | 25.93 | 177 / 178 |
uterus | 100% | 3266.32 | 170 / 170 | 99% | 25.37 | 454 / 459 |
bladder | 100% | 2693.76 | 21 / 21 | 99% | 21.06 | 497 / 504 |
liver | 100% | 1656.13 | 226 / 226 | 98% | 18.93 | 398 / 406 |
skin | 100% | 1998.57 | 1803 / 1809 | 94% | 26.51 | 442 / 472 |
adipose | 100% | 3260.29 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3292.63 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.30 | 29 / 29 |
spleen | 100% | 2275.22 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 22.26 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.72 | 1 / 1 |
muscle | 100% | 1344.89 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1375.55 | 846 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 78% | 1574.96 | 728 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 73% | 10.56 | 58 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007254 | Biological process | JNK cascade |
GO_0002244 | Biological process | hematopoietic progenitor cell differentiation |
GO_0003151 | Biological process | outflow tract morphogenesis |
GO_0110024 | Biological process | positive regulation of cardiac muscle myoblast proliferation |
GO_1990253 | Biological process | cellular response to leucine starvation |
GO_0060052 | Biological process | neurofilament cytoskeleton organization |
GO_0001701 | Biological process | in utero embryonic development |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0006974 | Biological process | DNA damage response |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_0003419 | Biological process | growth plate cartilage chondrocyte proliferation |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_0001889 | Biological process | liver development |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0001865 | Biological process | NK T cell differentiation |
GO_0006970 | Biological process | response to osmotic stress |
GO_0072740 | Biological process | cellular response to anisomycin |
GO_0007033 | Biological process | vacuole organization |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0044255 | Biological process | cellular lipid metabolic process |
GO_0030509 | Biological process | BMP signaling pathway |
GO_1990144 | Biological process | intrinsic apoptotic signaling pathway in response to hypoxia |
GO_0098586 | Biological process | cellular response to virus |
GO_1902110 | Biological process | positive regulation of mitochondrial membrane permeability involved in apoptotic process |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0003418 | Biological process | growth plate cartilage chondrocyte differentiation |
GO_0021754 | Biological process | facial nucleus development |
GO_0097284 | Biological process | hepatocyte apoptotic process |
GO_0003360 | Biological process | brainstem development |
GO_0006606 | Biological process | protein import into nucleus |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0021743 | Biological process | hypoglossal nucleus development |
GO_0042789 | Biological process | mRNA transcription by RNA polymerase II |
GO_0060612 | Biological process | adipose tissue development |
GO_0097049 | Biological process | motor neuron apoptotic process |
GO_1902742 | Biological process | apoptotic process involved in development |
GO_0021742 | Biological process | abducens nucleus development |
GO_0031573 | Biological process | mitotic intra-S DNA damage checkpoint signaling |
GO_0032915 | Biological process | positive regulation of transforming growth factor beta2 production |
GO_0060245 | Biological process | detection of cell density |
GO_0038066 | Biological process | p38MAPK cascade |
GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0050872 | Biological process | white fat cell differentiation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_1902562 | Cellular component | H4 histone acetyltransferase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0000785 | Cellular component | chromatin |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0043522 | Molecular function | leucine zipper domain binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0010485 | Molecular function | histone H4 acetyltransferase activity |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0004402 | Molecular function | histone acetyltransferase activity |
GO_0035497 | Molecular function | cAMP response element binding |
GO_0044013 | Molecular function | histone H2B acetyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008140 | Molecular function | cAMP response element binding protein binding |
Gene name | ATF2 |
Protein name | Activating transcription factor 2 splice variant ATF2-var12 Activating transcription factor 2 splice variant ATF2-var0 (Activating transcription factor 2 splice variant ATF2-var3) (Activating transcription factor 2 splice variant ATF2-var7) Activating transcription factor 2 splice variant ATF2-var10 (Activating transcription factor 2 splice variant ATF2-var4) Activating transcription factor 2 Cyclic AMP-dependent transcription factor ATF-2 Activating transcription factor 2 splice variant ATF2-var6 (Activating transcription factor 2 splice variant ATF2-var9) Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (HB16) (cAMP response element-binding protein CRE-BP1) |
Synonyms | CREBP1 CREB2 |
Description | FUNCTION: Transcriptional activator which regulates the transcription of various genes, including those involved in anti-apoptosis, cell growth, and DNA damage response. Dependent on its binding partner, binds to CRE (cAMP response element) consensus sequences (5'-TGACGTCA-3') or to AP-1 (activator protein 1) consensus sequences (5'-TGACTCA-3'). In the nucleus, contributes to global transcription and the DNA damage response, in addition to specific transcriptional activities that are related to cell development, proliferation and death. In the cytoplasm, interacts with and perturbs HK1- and VDAC1-containing complexes at the mitochondrial outer membrane, thereby impairing mitochondrial membrane potential, inducing mitochondrial leakage and promoting cell death. The phosphorylated form (mediated by ATM) plays a role in the DNA damage response and is involved in the ionizing radiation (IR)-induced S phase checkpoint control and in the recruitment of the MRN complex into the IR-induced foci (IRIF). Exhibits histone acetyltransferase (HAT) activity which specifically acetylates histones H2B and H4 in vitro . In concert with CUL3 and RBX1, promotes the degradation of KAT5 thereby attenuating its ability to acetylate and activate ATM. Can elicit oncogenic or tumor suppressor activities depending on the tissue or cell type. . FUNCTION: Transcriptional activator which regulates the transcription of various genes, including those involved in anti-apoptosis, cell growth, and DNA damage response. Dependent on its binding partner, binds to CRE (cAMP response element) consensus sequences (5'-TGACGTCA-3') or to AP-1 (activator protein 1) consensus sequences (5'-TGACTCA-3'). . FUNCTION: Transcriptional activator which regulates the transcription of various genes, including those involved in anti-apoptosis, cell growth, and DNA damage response. Dependent on its binding partner, binds to CRE (cAMP response element) consensus sequences (5'-TGACGTCA-3') or to AP-1 (activator protein 1) consensus sequences (5'-TGACTCA-3'). . |
Accessions | ENST00000415955.5 ENST00000264110.7 [P15336-1] B8ZZU6 ENST00000417080.5 ENST00000409437.5 F2Z2K2 ENST00000392544.5 [P15336-1] ENST00000409635.5 [P15336-4] ENST00000345739.9 [P15336-4] E9PBF9 E9PEK8 ENST00000409833.5 [P15336-3] ENST00000435004.6 A4D7U9 ENST00000428760.5 A4D7V5 A4D7U3 ENST00000421438.5 ENST00000409499.5 [P15336-8] ENST00000426833.7 [P15336-5] ENST00000456655.5 A4D7U7 H7C2N6 ENST00000429579.5 C9JCI8 ENST00000435231.6 P15336 ENST00000437522.5 |